None listed
Conditions
Interventions
Patients who meet the inclusion creteria were given a continuous intravenous infusion of Dexmedetomidine (0.4 - 1.0mic/kg/hr) up to 7 days.
Sponsors
Prince of Wales Hospital
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1.Patient requiring invasive ventilation for longer than 24 hours. 2.Receiving narcotics and /or sedatives for longer than 24 hours. 3.Development of clinical agitation and/or delirium upon weaning narcotics and/or sedatives on commencement of weaning from mechanical ventilation 4.Informed consent signed by person responsible within 24 hours of enrolment. 5. Have failed conventional sedative therapy as assessed by the treating intensivist.
Exclusion criteria
1.Allergy to Dexmedetomidine.2.Patients who are or likely to be pregnant or lactating.3.Patients receiving other long term alpha 2 agonists.4. Involvement in a sedation study within the last 30 days.5. Known opiate or benzodiazepines dependence, treatment for chronic pain or recent detoxification therapy within the last 6 months. 6. Patients on anti-psychotic drugs 7. Known dementia, Parkinsonism or epilepsy.8. Patients with recent cerebro-vascular surgery or traumatic brain injury.9. Any evidence of critical illness polyneuropathy.10. Recent surgery involving free flap.11. Haemodynamically unstable patients with Systolic blood pressure < 90 mmHg and or Heart rate < 55 / min.12. Patients on CVVHD.13. Patients with hepatic encephalopathy within 14 days.14. Patients with a recent drug overdose or CO poisoning.
Outcome results
None listed